Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
34.71
+0.71 (2.09%)
At close: Jul 14, 2025, 4:00 PM
34.71
0.00 (0.00%)
After-hours: Jul 14, 2025, 4:04 PM EDT
HRMY Stock Forecast
Stock Price Forecast
The 9 analysts that cover HRMY stock have a consensus rating of "Strong Buy" and an average price target of $54.44, which forecasts a 56.84% increase in the stock price over the next year. The lowest target is $40 and the highest is $70.
Price Target: $54.44 (+56.84%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HRMY stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $54 → $55 | Strong Buy | Maintains | $54 → $55 | +58.46% | Jul 10, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $61 | Buy | Initiates | $61 | +75.74% | Jun 2, 2025 |
| Mizuho | Mizuho | Buy Maintains $44 → $48 | Buy | Maintains | $44 → $48 | +38.29% | May 15, 2025 |
| Needham | Needham | Strong Buy Reiterates $49 | Strong Buy | Reiterates | $49 | +41.17% | May 7, 2025 |
| Needham | Needham | Strong Buy Reiterates $49 | Strong Buy | Reiterates | $49 | +41.17% | May 6, 2025 |
Financial Forecast
Revenue This Year
860.04M
from 714.73M
Increased by 20.33%
Revenue Next Year
1.01B
from 860.04M
Increased by 17.67%
EPS This Year
3.37
from 2.51
Increased by 34.21%
EPS Next Year
4.34
from 3.37
Increased by 28.76%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 901.0M | 1.1B | 1.3B | ||
| Avg | 860.0M | 1.0B | 1.2B | ||
| Low | 809.6M | 915.1M | 1.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.1% | 29.2% | 29.4% | ||
| Avg | 20.3% | 17.7% | 15.6% | ||
| Low | 13.3% | 6.4% | 0.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.40 | 6.34 | 8.16 | ||
| Avg | 3.37 | 4.34 | 5.28 | ||
| Low | 2.16 | 2.79 | 4.02 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 75.3% | 88.3% | 88.1% | ||
| Avg | 34.2% | 28.8% | 21.7% | ||
| Low | -14.1% | -17.1% | -7.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.